Corpus Intelligence IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP 2026-04-26 05:29 UTC
IC Memo — ENCOMPASS HEALTH REHABILITATION HOSP
Investment Committee Memorandum | WV | 41 beds | Grade C | EBITDA uplift $1.7M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

ENCOMPASS HEALTH REHABILITATION HOSP

CCN 513027 | WOOD, WV | 41 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

ENCOMPASS HEALTH REHABILITATION HOSP is a 41-bed suburban community hospital in WOOD, WV with $22.6M in net patient revenue and a 20.6% operating margin. The hospital serves a payer mix of 69.3% Medicare, 2.0% Medicaid, and 28.7% commercial.

Thesis: Turnaround. Our ML models identify $1.7M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from 20.6% to 28.0% (+736bps).

Net Revenue HCRIS$22.6M
Current EBITDA COMPUTED$4.7M
Operating Margin COMPUTED20.6%
Occupancy HCRIS91.4%
Revenue / Bed COMPUTED$552K
Net-to-Gross HCRIS70.4%
Distress Probability ML45.1%

2. Market Context & Competitive Position

62
WV Hospitals
-0.3%
State Median Margin
34
Comparable Hospitals

WV has 62 Medicare-certified hospitals with a median operating margin of -0.3%. The target's margin of 20.6% places it above the state median. Among 34 size-comparable peers (20-82 beds), the median margin is 1.3%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (20-82), prioritizing same-state peers. 34 hospitals in the comp set.

HospitalStateBedsRevenueMargin
ENCOMPASS HEALTH REHABILITATIO (Target)WV41$22.6M20.6%
BECKLEY ARHWV72$109.2M-37.8%
ST. JOSEPHS HOSPITAL OF BUCKHAWV25$101.4M15.7%
JEFFERSON MEMORIAL HOSPITALWV25$85.5M9.7%
POTOMAC VALLEY HOSPITALWV25$69.5M16.2%
BOONE MEMORIAL HOSPITALWV25$61.8M-12.0%
SUMMERSVILLE REGIONAL MED CENTWV25$60.6M0.3%
ST FRANCIS HOSPITALWV40$58.5M30.5%
GREENBRIER VALLEY MEDICAL CENTWV58$50.8M4.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $1.7M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$475K+210bp18mo
Cost to Collect4.5%2.5%$452K+200bp12mo
Denial Rate Reduction12.0%6.5%$448K+198bp12mo
A/R Days Reduction5200.0%3800.0%$275K+122bp9mo
Clean Claim Rate88.0%96.0%$14K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$475K
Cost to Collect
$452K
Denial Rate Reduction
$448K
A/R Days Reduction
$275K
Clean Claim Rate
$14K
Total EBITDA Uplift$1.7M
Current EBITDA$4.7M
+ RCM Uplift+$1.7M
Pro Forma EBITDA$6.3M
Current Margin20.6%
Pro Forma Margin28.0%
WC Released (1x)$868K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$7.2M$47.4M6.61x45.9%
Base (11x exit)10.0x11.0x$7.2M$54.5M7.60x50.0%
Bull Case9.0x11.0x$6.5M$62.3M9.65x57.4%
Bull (12x exit)9.0x12.0x$6.5M$69.9M10.82x61.0%
Bear Case11.0x10.0x$7.9M$36.7M4.66x36.0%
Bear (11x exit)11.0x11.0x$7.9M$43.0M5.45x40.4%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
MediumHeavy Medicare dependenceMedicare comprises 69.3% of days; rate updates may lag inflation. Mitigant: CDI/CMI lever directly increases Medicare reimbursement

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 34 hospitals with 20-82 beds
  • Same-state prioritization (n=35)
  • Comp margins: P25=-12.8% / P50=1.3% / P75=10.3%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.